Specifically, the upregulation of IgG containing immunoglobulin heavy constant chain gamma 1 (IGHG1) is strongly associated with various malignancies, including colorectal cancer, gastric cancer, prostate cancer, papillary thyroid carcinoma, leukemia, ovarian cancer, and breast cancer [6–8]. This evidence concerns the gene IGHG1 and prostate cancer.